CN Patent
CN117295510A — 一种钙敏感受体激动剂的组合物及其应用
Assigned to Beijing Tuojie Biomedical Technology Co ltd · Expires 2023-12-26 · 2y expired
What this patent protects
提供一种钙敏感受体激动剂的组合物及其应用。具体而言,提供一种多肽钙敏感受体激动剂的药物组合物,所述组合物包含活性成分、缓冲剂和渗透压调节剂。本组合物稳定性高,可长期储存,可有效降低血浆甲状旁腺激素,且组胺释放水平低。
USPTO Abstract
提供一种钙敏感受体激动剂的组合物及其应用。具体而言,提供一种多肽钙敏感受体激动剂的药物组合物,所述组合物包含活性成分、缓冲剂和渗透压调节剂。本组合物稳定性高,可长期储存,可有效降低血浆甲状旁腺激素,且组胺释放水平低。
Drugs covered by this patent
- Parsabiv (ETELCALCETIDE) · Kai Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.